

Women who have a history of substance abuse, neuropsychiatric impairment, or mental illness are less likely to undergo gynecological screening tests for cervical cancer and have a greater than doubled risk of getting the disease. Researchers from the Karolinska Institutet published their findings in The Lancet Public Health and emphasized the value of proactively interacting with these women as a cervical cancer prevention strategy.
The WHO announced a global plan in May 2020 to end cervical cancer as a concern affecting women’s health. A requirement that 70% of women get the illness screening at least twice before the ages of 35 and 45 is a component of the approach.
One of the main obstacles to this goal, according to the experts, is care inequity. “Our study identified a high-risk group that needs extra attention if we’re to succeed in eliminating cervical cancer,” says one of the study’s first authors Kejia Hu, postdoc researcher at the Institute of Environmental Medicine at Karolinska Institutet.
More than four million women born between 1940 and 1995 were a part of the observational study. The researchers used this population to estimate the risk of cervical cancer, precancerous cervical lesions, and participation in cervical cancer screening programs, contrasting women with diagnoses of mental illness, neuropsychiatric disability, or substance abuse with women without such diagnoses.
“Our results suggest that women with these diagnoses participate more seldom in screening programs at the same time as they have a higher incidence of lesions in the cervix,” says Dr. Hu. “We thus found that they have twice the risk of developing cervical cancer.”
All diseases were associated with an enhanced risk, but substance abuse was the one with the strongest correlation. The researchers concluded that women with mental illness should be made more aware of the value of routine gynecological screening:
“It would lower their risk of cancer,” says one of the paper’s authors Karin Sundström, senior researcher at the Department of Laboratory Medicine, Karolinska Institutet. “Similarly, if healthcare professionals are more aware of the cancer risk in these patients, they can step up preventative measures and consider how these could be delivered to potentially under-served patients.”
The strength of the study lies in the sheer size of the cohort and the length of the time-span period over which the participants were studied. One limitation is that the researchers did not have full data about other risk factors for cervical cancer such as smoking, hormonal contraceptives, and sexually transmitted diseases.
more recommended stories
Philippines Strengthens ASF Detection and Control
Innovative Solutions for Rapid ASF Detection.
Key Immune Pathways in Centenarians Identified
Centenarians Offer Clues to Healthy Aging.
Action Video Games and Brain Health: Study Insights
Gaming and Brain Structure: What MRI.
Creatine May Boost Muscle Strength in Alzheimer’s Patients
Creatine Supplementation Shows Promise in Alzheimer’s.
New Drug STF-1623 Shows Promise in Treating Solid Tumors
STF-1623 Transforming ‘Cold’ Tumors into ‘Hot’.
Macrophage Microautophagy Supports Immune Readiness
A Breakthrough in Cellular Recycling Macrophages,.
The Role of α-Glucosidase in Type 2 Diabetes
α-Glucosidase Inhibition: Functional Food Compounds for.
Oral Bacteria Linked to Atherosclerosis
New Evidence Links Viridans Streptococci to.
CDI Test Shows Early Detection Potential in Alzheimer’s
Breakthrough Study Highlights Brain Blood Flow.
Prenatal Chlorpyrifos Exposure and Pediatric Brain Changes
A Growing Concern in Pediatric Neurodevelopment.
Leave a Comment